Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

New alopecia treatments aim for better results and fewer side effects.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Isotretinoin at a low dose for three months does not significantly affect hair growth.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

The iron supplement effectively improves iron levels and reduces symptoms with good tolerance.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Post-steroid panniculitis is now rare because doctors taper steroids more carefully.

Female hair loss patients more likely to have dry eye and gland issues.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.